A Low-Modulus Phosphatidylserine-Exposing Microvesicle Alleviates Skin Inflammation via Persistent Blockade of M1

Zihao Zhang1, Yidi Mo1, Shengxia Xu1

  • 1Guangdong Provincial Key Laboratory of Bioengineering Medicine, Department of Cell Biology, Jinan University, Guangzhou 510632, China.

Insights

Researchers developed deformed phosphatidylserine-exposing microvesicles (D-PSVs) that effectively treat inflammatory skin diseases. These D-PSVs target macrophages, reduce inflammation, and improve skin conditions by modulating immune responses.

Area of Science:

  • Immunology
  • Dermatology
  • Biotechnology

Background:

  • Inflammatory skin diseases impair skin barrier function, quality of life, and mental health.
  • Overactive immune responses are central to these conditions.
  • Current treatments may have limitations in efficacy and delivery.

Purpose of the Study:

  • To develop and evaluate a novel microvesicle-based therapy for inflammatory skin diseases.
  • To investigate the therapeutic potential of low-modulus phosphatidylserine-exposing microvesicles (D-PSVs).
  • To assess the efficacy of D-PSVs in modulating macrophage polarization and skin inflammation.

Main Methods:

  • Production and characterization of deformed phosphatidylserine-exposing microvesicles (D-PSVs).
  • In vitro assessment of D-PSV anti-inflammatory effects on macrophages stimulated with lipopolysaccharides and interferon-γ.
  • Transcriptome analysis to identify D-PSV-modulated signaling pathways.
  • In vivo evaluation of D-PSV efficacy in an imiquimod-induced psoriatic dermatitis mouse model.

Main Results:

  • D-PSVs demonstrated a more robust and sustained inhibition of inflammatory responses compared to conventional PSVs (C-PSVs).
  • Transcriptome analysis revealed that D-PSVs modulate inflammation-related pathways, reducing pro-inflammatory gene expression.
  • Topical D-PSV application significantly reduced skin inflammation and lesion severity in a mouse model.
  • Enhanced skin permeability and macrophage adhesion of D-PSVs contributed to their therapeutic effects.

Conclusions:

  • Macrophage-targeted D-PSVs offer a promising non-invasive therapeutic strategy for inflammatory skin diseases.
  • D-PSVs effectively inhibit M1 macrophage polarization and restore immune microenvironment balance.
  • The unique properties of D-PSVs lead to superior therapeutic outcomes in managing skin inflammation.